site stats

Chemotherapy platinum agents

WebChemotherapy-induced peripheral neuropathy (CIPN) is a major dose-limiting side effect of many commonly used chemotherapeutic agents, including platinum drugs, taxanes, epothilones, and vinca alkaloids, but also newer agents such as bortezomib and lenolidamide. Neurotoxic chemotherapeutic agents may cause structural damage to … WebThis is a list of chemotherapeutic agents, also known as cytotoxic agents or cytostatic drugs, that are known to be of use in chemotherapy for cancer.This list is organized by type of agent, although the subsections are not necessarily definitive and are subject to …

Cancer Chemotherapy and Antioxidants The Journal of …

WebOct 6, 1999 · Despite identified limitations in the grading and reporting of treatment-related anemia, which are evidenced in this review, the collective results confirm a relatively high incidence of mild-to-moderate anemia across the major nonmyeloid tumors treated with the most commonly used single agents and combination chemotherapy regimens. … WebPlatinum drugs are important components of multiagent chemotherapy regimens for numerous malignancies, including sarcomas, and tumors of the testes, ovary, bladder, lung, brain, head and neck, and others (Kelland, 2007). Cisplatin is known to produce … forest closures new mexico https://collectivetwo.com

National Center for Biotechnology Information

The first platinum-based chemotherapy drug, cisplatin, was approved for use by the FDA in 1978Trusted Source. Researchers are continuing to examine newer drugs that may cause fewer side effects. See more Platinum-based chemotherapy drugs can cause serious complications, such as cognitive changes or cardiovascular problems. Your doctor may recommend lowering your dose or stopping treatment if you develop severe … See more Researchers are continuing to examine whether platinum-based chemotherapy is safe for people who are pregnant or breastfeeding. In a small 2024 study, researchers found evidence that it might be reasonably safe … See more According to the American Cancer SocietyTrusted Source, it’s generally not recommended to receive a vaccine during chemotherapy or radiation treatment. The exception is the flu … See more A dose-limiting side effect is a side effect that’s serious enough to prevent doctors from increasing the dose of the drug further. The dose-limiting side effect of cisplatin is nephrotoxicity, the deterioration of your kidney … See more WebSep 22, 2010 · Based on the BRCA1 dysfunction phenotype of BLBC, one approach has been the exploration of platinum chemotherapy agents (carboplatin, cisplatin, and others) in these patients. Platinum agents produce DNA cross-links, which lead to DNA double-strand breaks, normally repaired by BRCA½-mediated high-fidelity homologous … WebDec 21, 2024 · Platinum (Pt) agents, usually referring to carboplatin (Cb) and cisplatin(DDP), are cytotoxic DNA-damaging chemo-drugs widely used in various malignancies. Platinum can cause DNA strand breaks ... forest cmc

Inclusion of Platinum Agents in Neoadjuvant …

Category:Oxaliplatin: Uses, Dosage, Side Effects, Warnings - Drugs.com

Tags:Chemotherapy platinum agents

Chemotherapy platinum agents

Platinum-based agents for individualized cancer treatment

WebMay 29, 2014 · Abstract. The platinum-based drugs cisplatin, carboplatin, and oxaliplatin belong to the most widely used chemotherapeutics in oncology, showing clinical efficacy against many solid tumors. Their main mechanism of action is believed to be the induction of cancer cell apoptosis as a response to their covalent binding to DNA. In recent years, … WebApr 13, 2024 · Triple-negative breast cancer (TNBC) is the most aggressive and lethal breast cancer (BC) subtype. 1 Chemotherapy still represents the backbone of the first-line treatment for patients with advanced TNBC (aTNBC). In patients with programmed death …

Chemotherapy platinum agents

Did you know?

WebMar 10, 2024 · Platinum agents. Examples of platinum agents include cisplatin, carboplatin and oxaliplatin. Each agent contains a platinum ion, surrounded by organic ligands, that carries out its action on DNA strands. These agents are commonly used in the management of ovarian, colorectal, lung and bladder cancers. WebOct 22, 2024 · A 2024 study notes that platinum-based chemotherapy drugs are associated with about 40 different side effects, ranging from nausea and vomiting to anaphylaxis (severe allergic reaction) and cytopenia.

WebAlkylating agents are compounds that work by adding an alkyl group to the guanine base of the DNA molecule, preventing the strands of the double helix from linking as they should. ... Note: Although the platinum-containing anticancer agents, carboplatin, cisplatin, and oxaliplatin are frequently classified as alkylating agents, they are not ...

WebApr 4, 2024 · Oxaliplatin is a cytotoxic chemotherapy drug used to treat cancer. It is a type of platinum drug and an alkylating agent. Like other alkylating agents, oxaliplatin works by interfering with the development of DNA in a cell. It … WebChemotherapy is the use of drugs to destroy cancer cells. This type of cancer treatment works by keeping cancer cells from growing, dividing, and making more cells. Chemotherapy can be used as a treatment for many different cancers. Your doctor may refer to chemotherapy as standard chemotherapy, traditional chemotherapy, or …

WebApr 1, 2024 · Among platinum-based cancer drugs, cisplatin, oxaliplatin, and carboplatin are the top three most used platinum chemotherapy agents . Cisplatin, the first FDA-approved platinum compound for chemotherapy, is the most commonly used drug in the treatment of several cancers, including testicular cancer, ovarian cancer, head and neck …

WebChemotherapy-associated PRES is an increasingly encountered syndrome. Both neurologists and non-neurologists should be familiar with the most commonly implicated agents, symptoms, risk factors, and clinical course of chemotherapy-associated PRES, given its favorable prognosis with appropriate manage … forest club lake maryWebMay 20, 2010 · Platinum-containing chemotherapy agents (cisplatin, carboplatin, oxaliplatin) have been approved in the first-line setting of numerous malignancies, such as ovarian, bladder, head and neck, colorectal, and lung cancer. Their extensive use over the last decade has led to a significant increase in the incidence of hypersensitivity reactions, … forest coaches bucknellWebApr 11, 2024 · Compared with using chemotherapy alone, anti-angiogenic agents, targeted therapy, and immunotherapy can provide more benefits in survival rate for recurrent platinum resistance. Although various anti-cancer agents are used in treating recurrent platinum-resistant ovarian cancer, there is no consensus on the international standards … forest coaches limited